Alyssa Vito
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline.
Journal: Current oncology (Toronto, Ont.)
Published: May 02, 2025
Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer: A Systematic Review.
Journal: Current oncology (Toronto, Ont.)
Published: March 04, 2025
Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells.
Journal: Cancers
Published: January 18, 2023
A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent Manner.
Journal: International journal of molecular sciences
Published: December 16, 2021
IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity.
Journal: Molecular therapy oncolytics
Published: December 08, 2021
Response to FEC Chemotherapy and Oncolytic HSV-1 Is Associated with Macrophage Polarization and Increased Expression of S100A8/A9 in Triple Negative Breast Cancer.
Journal: Cancers
Published: September 02, 2021
Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer.
Journal: International journal of molecular sciences
Published: April 08, 2021
Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells.
Journal: Communications biology
Published: January 28, 2021
Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy.
Journal: Cancers
Published: January 26, 2021
Genetic modification of oncolytic viruses to enhance antitumor immunity.
Journal: Methods in enzymology
Published: March 04, 2020
Last Updated: 09/26/2026